Corrigendum: How to hit mesenchymal stromal cells and make the tumor microenvironment immunostimulant rather than immunosuppressive [Front Immunol, 9 (2018) 262] DOI: 10.3389/fimmu.2018.00262

Research output: Contribution to journalComment/debatepeer-review

Abstract

There is an error in the Funding statement. The correct name for one of the funders is Ministero della Salute. The correct Funding statement is: This work has been partially supported by grants from AIRC to AP (IG15483) and AIRC to MZ (IG17074) and from 5xmille 2012 Ministero della Salute, 5xmille 2013 Ministero della Salute, 5xmille 2014 Ministero della Salute, and 5xmille 2015 Ministero della Salute to AP. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Original languageEnglish
Article number1342
JournalFrontiers in Immunology
Volume9
Issue numberJUN
DOIs
Publication statusPublished - Jun 11 2018

Keywords

  • Carcinoma-associated fibroblast
  • Immunosuppression
  • Mesenchymal stromal cells
  • Tumor microenvironment
  • Tumor-associated fibroblast

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Corrigendum: How to hit mesenchymal stromal cells and make the tumor microenvironment immunostimulant rather than immunosuppressive [Front Immunol, 9 (2018) 262] DOI: 10.3389/fimmu.2018.00262'. Together they form a unique fingerprint.

Cite this